KQED is a proud member of
Save ArticleSave Article
KQED Radio
KQED Newssee more
Radio Schedule
Latest Newscasts:KQEDNPR
Player Sponsored By
upper waypoint
Forum

Theranos Under Scrutiny After WSJ Criticism

Mina Kim
at
Save ArticleSave Article
Failed to save article

Please try again

 (Andrew Burton/Getty Images)

Bay Area-based Theranos is coming under scrutiny after a Wall Street Journal article questioned the accuracy of the company’s blood-testing technology. Since the article, plans for a $350 million partnership with Safeway fell through. Theranos, which is valued at $9 billion, hired a high-profile Supreme Court lawyer and is weighing a defamation lawsuit against the paper. We’ll get the latest on Theranos and its recent interactions with the FDA and Capitol Hill.

Sponsored

lower waypoint
next waypoint
Supreme Court Hears Oral Arguments in Major Homelessness CasePercival Everett’s Novel “James” Recenters the Story of Huck FinnHave We Entered Into a New Cold War Era?KQED Youth Takeover: How Social Media is Changing Political AdvertisingDeath Doula Alua Arthur on How and Why to Prepare for the EndHow to Create Your Own ‘Garden Wonderland’First Trump Criminal Trial Underway in New YorkThe Beauty in Finding ‘Other People’s Words’ in Your OwnWhat the 99 Cents Only Stores Closure Means to CaliforniansBay Area Diaspora Closely Watching India’s Upcoming Election